Paul J. Mellett

Paul J. Mellett

Chief Financial and Administrative OfficeratEnanta Pharmaceuticals· In proxies 2021–2024

Pay in FY2024-60% from the year before · Enanta Pharmaceuticals stock -7.3% the same year

Paul J. Mellett was paid $1.1M in FY2024 (Sep), down 60%. Enanta Pharmaceuticals stock fell 7.3% that year.

Pay$100 in the stock at the end of FY20 → $23
Pay is from the Summary Compensation Table of each Enanta Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Enanta PharmaceuticalsPublic company · 5 yr
    • Chief Financial and Administrative Officer2021 – Present · 5 yrStock in role -73%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?